Literature DB >> 15829023

Epidemiology and microbiology of subclinical mastitis among HIV-infected women in Malawi.

V Nussenblatt1, V Lema, N Kumwenda, R Broadhead, M C Neville, T E Taha, R D Semba.   

Abstract

The epidemiology and microbiology of subclinical mastitis, a risk factor for perinatal HIV transmission, have not been well characterized. In all, 250 HIV-infected women were followed from two weeks to 12 months postpartum in Blantyre, Malawi, and subclinical mastitis was assessed by breast milk leukocyte counts. The point prevalence of subclinical mastitis at 2, 4, 6, 10, and 14 weeks, and 6, 9, and 12 months was 12.2%, 7.8%, 6.8%, 3.7%, 10.6%, 5.1%, 4.9%, and 1.9%, respectively (P = 0.002), and 27.2% of women had at least one episode of subclinical mastitis. There was no significant relationship between maternal plasma HIV load or parity and subclinical mastitis. Staphylococcus aureus was isolated in 30% of women with subclinical mastitis, and the proportion of women with positive cultures decreased during follow-up (P = 0.02). Subclinical mastitis is prevalent among breastfeeding mothers and further studies are needed to characterize the differences between infectious and non-infectious subclinical mastitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15829023     DOI: 10.1258/0956462053420248

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  16 in total

1.  Exclusive breastfeeding, maternal HIV disease, and the risk of clinical breast pathology in HIV-infected, breastfeeding women.

Authors:  Katherine Semrau; Louise Kuhn; Daniel R Brooks; Howard Cabral; Moses Sinkala; Chipepo Kankasa; Donald M Thea; Grace M Aldrovandi
Journal:  Am J Obstet Gynecol       Date:  2011-06-15       Impact factor: 8.661

Review 2.  Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE).

Authors:  Daniel J Raiten; Fayrouz A Sakr Ashour; A Catharine Ross; Simin N Meydani; Harry D Dawson; Charles B Stephensen; Bernard J Brabin; Parminder S Suchdev; Ben van Ommen
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

3.  HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells.

Authors:  Sharof M Tugizov; Rossana Herrera; Piri Veluppillai; Deborah Greenspan; Vanessa Soros; Warner C Greene; Jay A Levy; Joel M Palefsky
Journal:  Virology       Date:  2010-11-05       Impact factor: 3.616

4.  Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epithelia.

Authors:  Sharof M Tugizov; Rossana Herrera; Piri Veluppillai; Deborah Greenspan; Vanessa Soros; Warner C Greene; Jay A Levy; Joel M Palefsky
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

5.  Vitamin supplementation increases risk of subclinical mastitis in HIV-infected women.

Authors:  Joanne E Arsenault; Said Aboud; Karim P Manji; Wafaie W Fawzi; Eduardo Villamor
Journal:  J Nutr       Date:  2010-08-25       Impact factor: 4.798

6.  Subclinical mastitis occurs frequently in association with dramatic changes in inflammatory/anti-inflammatory breast milk components.

Authors:  Edouard Tuaillon; Johanes Viljoen; Pierre Dujols; Gilles Cambonie; Pierre-Alain Rubbo; Nicolas Nagot; Ruth M Bland; Stéphanie Badiou; Marie-Louise Newell; Philippe Van de Perre
Journal:  Pediatr Res       Date:  2016-11-04       Impact factor: 3.756

7.  Breast milk alpha-defensins are associated with HIV type 1 RNA and CC chemokines in breast milk but not vertical HIV type 1 transmission.

Authors:  Rose Bosire; Grace C John-Stewart; Jennifer M Mabuka; Grace Wariua; Christine Gichuhi; Dalton Wamalwa; John Ruzinski; Richard Goodman; Barbara Lohman; Dorothy A Mbori-Ngacha; Julie Overbaugh; Carey Farquhar
Journal:  AIDS Res Hum Retroviruses       Date:  2007-02       Impact factor: 2.205

8.  Cytomegalovirus and Epstein-Barr virus in breast milk are associated with HIV-1 shedding but not with mastitis.

Authors:  Soren Gantt; Jacquelyn Carlsson; Avinash K Shetty; Kristy D Seidel; Xuan Qin; Junior Mutsvangwa; Georgina Musingwini; Godfrey Woelk; Lynn S Zijenah; David A Katzenstein; Lisa M Frenkel
Journal:  AIDS       Date:  2008-07-31       Impact factor: 4.177

9.  Potent simian immunodeficiency virus-specific cellular immune responses in the breast milk of simian immunodeficiency virus-infected, lactating rhesus monkeys.

Authors:  Sallie R Permar; Helen H Kang; Angela Carville; Keith G Mansfield; Rebecca S Gelman; Srinivas S Rao; James B Whitney; Norman L Letvin
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

10.  Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells.

Authors:  Rossana Herrera; Michael Morris; Kristina Rosbe; Zhimin Feng; Aaron Weinberg; Sharof Tugizov
Journal:  Virology       Date:  2015-11-02       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.